Quang X. Pham, Chairman, CEO and Interim CFO, 10% Owner at Cadrenal Therapeutics, Inc. (CVKD), sold 18,124 shares at $4.12 ($70K) on 2026-06-11, disclosed to the SEC on 2026-06-15.
Scheduled sale ($70k) by Chairman, CEO and Interim CFO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.12 | 1,462 | $6K | 8.6% |
| 2 | $3.94 | 12,996 | $51K | 72.8% |
| 3 | $3.58 | 3,666 | $13K | 18.7% |
| Total | $3.88 avg | 18,124 | $70K | 100% |
| Filing → |
| CVKD | SELL | 2026-06-24 | $40K | — | Filing → |
| CVKD | SELL | 2026-06-18 | $13K | — | Filing → |
| CVKD | SELL | 2026-06-10 | $93K | — | Filing → |